Health
FDA Leader Says He Has No Plan to Act on Abortion Pill Access
Martin Makary at the Semafor World Economy Summit in Washington, DC, on April 24.
Photographer: Kent Nishimura/BloombergThis article is for subscribers only.
Food and Drug Administration Commissioner Marty Makary said he has no plans to change government policy on the abortion pill mifepristone, a hot-button issue in the US since the Supreme Court overturned the landmark Roe v. Wade decision in 2022.
Makary would reconsider the issue if new data emerged that signaled a safety issue with the drug that is now used in more than half of US abortions, he said during an appearance at the Semafor World Economy Summit on Thursday.